Sumitomo Mitsui Trust Group
LEGN icon

Sumitomo Mitsui Trust Group’s Legend Biotech LEGN Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.01M Buy
173,561
+6,971
+4% +$188K ﹤0.01% 726
2026
Q1 		$3.01M Hold
166,590
– – ﹤0.01% 752
2025
Q4 		$3.62M Buy
166,590
+396
+0.2% +$11.3K ﹤0.01% 756
2025
Q3 		$5.42M Buy
166,194
+3,585
+2% +$132K ﹤0.01% 724
2025
Q2 		$5.77M Sell
162,609
-11,157
-6% -$362K ﹤0.01% 706
2025
Q1 		$5.9M Hold
173,766
– – ﹤0.01% 720
2024
Q4 		$5.65M Sell
173,766
-3,461
-2% -$143K ﹤0.01% 735
2024
Q3 		$8.64M Buy
177,227
+14,672
+9% +$782K 0.01% 723
2024
Q2 		$7.2M Sell
162,555
-2,018
-1% -$93.1K 0.01% 731
2024
Q1 		$9.23M Buy
164,573
+1,443
+0.9% +$87K 0.01% 776
2023
Q4 		$9.82M Buy
163,130
+22,376
+16% +$1.42M 0.01% 771
2023
Q3 		$9.45M Sell
140,754
-2,349
-2% -$163K 0.01% 788
2023
Q2 		$9.88M Buy
143,103
+3,947
+3% +$258K 0.01% 790
2023
Q1 		$6.71M Buy
139,156
+19,985
+17% +$977K 0.01% 816
2022
Q4 		$5.95M Buy
119,171
+8,043
+7% +$390K ﹤0.01% 825
2022
Q3 		$4.53M Buy
111,128
+8,612
+8% +$404K ﹤0.01% 853
2022
Q2 		$5.64M Buy
102,516
+4,613
+5% +$195K ﹤0.01% 853
2022
Q1 		$3.56M Buy
97,903
+23,107
+31% +$913K ﹤0.01% 890
2021
Q4 		$3.49M Buy
+74,796
New +$3.79M ﹤0.01% 864

Other funds holding LEGN

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return
ELI
Empire Life Investments Toronto, Ontario, Canada $1.79B AUM 38.49% 1-Year Est. Return
IGAM
iA Global Asset Management Quebec, Quebec, Canada $8.42B AUM 47.61% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
RBI
Raiffeisen Bank International Vienna, Austria $8.53B AUM 46.94% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Sumitomo Mitsui Trust Group's LEGN Position: Q2 2026 in Review

Sumitomo Mitsui Trust Group increased its Legend Biotech (LEGN) stake by 4.2% in Q2 2026, buying an estimated $188K and bringing the position to 173,561 shares worth $5.01M. The position accounts for ﹤0.01% of the portfolio, ranked #726.

Sumitomo Mitsui Trust Group first reported a position in LEGN in Q4 2021 and has held it in 19 quarters since. The position peaked at $9.88M in Q2 2023. 47 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Sumitomo Mitsui Trust Group held 173,561 shares of Legend Biotech worth $5.01M as of Q2 2026.
  • Sumitomo Mitsui Trust Group bought 6,971 Legend Biotech shares in Q2 2026, an estimated $188K.
  • Legend Biotech made up ﹤0.01% of Sumitomo Mitsui Trust Group's portfolio in Q2 2026, its #726 holding.
  • Sumitomo Mitsui Trust Group first reported a position in Legend Biotech in Q4 2021 and has held it in 19 quarters since.
  • Sumitomo Mitsui Trust Group's Legend Biotech position peaked at $9.88M in Q2 2023.
  • 47 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q2 2026, filed 30 Jul 2026.